Arena Pharmaceuticals, Inc. et al v. Aurobindo Pharma Limited et al > Summary
Court Case Number 1:19-cv-00811
Filing Date May 1, 2019
Termination Date Mar 13, 2020
Court Delaware District Court
Status Dismissed - Settled
JudgesRichard G. Andrews
Plaintiff Attorneys
16Arena Pharmaceuticals
Attorney Name: Young J. Park
Paul Hastings
Arena Pharmaceuticals
Attorney Name: Anthony D. Raucci
Morris Nichols Arsht & Tunnell
Arena Pharmaceuticals
Attorney Name: Melanie R. Rupert
Paul Hastings
Arena Pharmaceuticals
Attorney Name: Bruce M. Wexler
Paul Hastings
356 Royalty Inc.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
356 Royalty Inc.
Attorney Name: Young J. Park
Paul Hastings
356 Royalty Inc.
Attorney Name: Anthony D. Raucci
Morris Nichols Arsht & Tunnell
356 Royalty Inc.
Attorney Name: Melanie R. Rupert
Paul Hastings
356 Royalty Inc.
Attorney Name: Bruce M. Wexler
Paul Hastings
Eisai Co., Ltd.
Attorney Name: Jack B. Blumenfeld
Morris Nichols Arsht & Tunnell
Eisai Co., Ltd.
Attorney Name: Young J. Park
Paul Hastings
Eisai Co., Ltd.
Attorney Name: Anthony D. Raucci
Morris Nichols Arsht & Tunnell
Eisai Co., Ltd.
Attorney Name: Melanie R. Rupert
Paul Hastings
Eisai Co., Ltd.
Attorney Name: Bruce M. Wexler
Paul Hastings
Arena Pharmaceuticals
Attorney Name: David C. Chen
Paul Hastings
Defendant Attorneys
2Aurobindo Pharma
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Aurobindo Pharma USA
Attorney Name: Kenneth L. Dorsney
Morris James LLP
Cause
35:271 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09770455 | Administration of an anti-obesity compound to individuals with renal impairment | Sep 26, 2017 |
| 08273734 | 5HT2C receptor modulators | Sep 25, 2012 |
| 08207158 | 5HT2c receptor modulators | Jun 26, 2012 |
| 07977329 | 5HT2C receptor modulators | Jul 12, 2011 |
| 07514422 | 5HT2c receptor modulators | Apr 7, 2009 |
| 06953787 | 5HT2C receptor modulators | Oct 11, 2005 |
